Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study

• Filipa Lynce,
• Candace Mainor,
• Renee N. Donahue,
• Xue Geng,
• Greg Jones,
• Ilana Schlam,
• Hongkun Wang,
• Nicole J. Toney,
• Caroline Jochems,
• Jeffrey Schlom,
• Jay Zeck,
• Christopher Gallagher,
• Rita Nanda,
• Deena Graham,
• Erica M. Stringer-Reasor,
• Neelima Denduluri,
• Julie Collins,
• Ami Chitalia,
• Shruti Tiwari,
• Raquel Nunes,
• Rebecca Kaltman,
• Katia Khoury,
• Margaret Gatti-Mays,
• Paolo Tarantino,
• Sara M. Tolaney,
• Sandra M. Swain,
• Paula Pohlmann,
• Heather A. Parsons,
• Claudine Isaacs

Affiliations

Filipa Lynce

Division of Medical Oncology, Dana-Farber Cancer Institute

Candace Mainor

MedStar Georgetown University Hospital

Renee N. Donahue

Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Xue Geng

Georgetown University

Greg Jones

NeoGenomics

Ilana Schlam

MedStar Washington Hospital Center

Hongkun Wang

Georgetown University

Nicole J. Toney

Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Caroline Jochems

Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Jeffrey Schlom

Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Jay Zeck

MedStar Georgetown University Hospital

Christopher Gallagher

MedStar Washington Hospital Center

Rita Nanda

University of Chicago

Deena Graham

Hackensack University Medical Center

Erica M. Stringer-Reasor

University of Alabama at Birmingham

Neelima Denduluri

AstraZeneca

Julie Collins

MedStar Georgetown University Hospital

Ami Chitalia

MedStar Washington Hospital Center

Shruti Tiwari

MedStar Washington Hospital Center

Raquel Nunes

Johns Hopkins Sidney Kimmel Cancer Center

Rebecca Kaltman

Inova

Katia Khoury

University of Alabama at Birmingham

Margaret Gatti-Mays

The Ohio State University

Paolo Tarantino

Division of Medical Oncology, Dana-Farber Cancer Institute

Sara M. Tolaney

Division of Medical Oncology, Dana-Farber Cancer Institute

Sandra M. Swain

Georgetown University

Paula Pohlmann

MedStar Georgetown University Hospital

Heather A. Parsons

Division of Medical Oncology, Dana-Farber Cancer Institute

Claudine Isaacs

Georgetown University